-transparent.png){kind=logo}
Chronic diphenylhydantoin (DPH) administration (5 mg x 100 g body wt-1 x day-1) to the normal rat is associated with a decrease in the serum thyroxine (T4) and triiodothyronine (T3) concentrations without an appropriate rise in the serum thyrotropin (TSH) concentration, suggesting a possible direct effect of DPH on TSH secretion. To further study this possibility, DPH was administered chronically to thyroidectomized, hypothyroid rats. In the hypothyroid rats treated chronically with DPH, serum TSH did not increase, pituitary TSH content was significantly decreased, and the serum TSH response to thyrotropin-releasing hormone (TRH) was decreased compared to that of diluent-treated, hypothyroid rats. Hypothalamic TRH content was similar in DPH and diluent-treated rats. These findings suggest that DPH suppresses pituitary TSH secretion, probably as a thyroid hormone agonist. The effect of a single large dose of DPH (20 mg/100 g body wt) administered to thyroidectomized rats also decreased serum tSH but, in contrast to the findings in chronically treated rats, hypothalamic TRH and pituitary TSH content and the serum TSH responses to TRH were increased. These differences may be due to the acute inhibitory effect of a large dose of DPH on hypothalamic TRH release. Furthermore, because the effect of thyroid hormone on regulating pituitary TSH synthesis and release is dose and time dependent, the effect of DPH as a thyroid hormone agonist on pituitary TSH dynamics may also be variable.
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
September 1978,
Metabolism: clinical and experimental,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
January 1965,
Acta physiologica Academiae Scientiarum Hungaricae,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
October 1974,
The Journal of clinical endocrinology and metabolism,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
January 1980,
Acta endocrinologica,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
December 1980,
Endocrinology,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
November 1987,
The Journal of clinical endocrinology and metabolism,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
March 1974,
European journal of pharmacology,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
February 1982,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
September 1975,
British medical journal,
T Theodoropoulos, and
S L Fang, and
F Azizi, and
S H Ingbar, and
A G Vagenakis, and
L E Braverman
May 1992,
The Journal of endocrinology,
